Affiliated Oncologists, LLC

Chicago Ridge, Illinois 60415

3 studies enrolling now · 8 studies all time

What they study most

Biliary Tract Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung, KRAS G12C Lung Cancer, Metastatic Prostate Cancer, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Receptors, Fibroblast Growth Factor, Relapsed or Refractory Multiple Myeloma, Urothelial Cancer

Studies at this site

• A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer — Recruiting now
• A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% — Recruiting now
• MYLUNG Consortium Part 3: Observational Study — Recruiting now
• Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet — Completed
• Breast Cancer Index (BCI) Registry — Running, not enrolling
• A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer — Completed
• Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer — Stopped early
• A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations — Completed